MYGN
Myriad Genetics Inc
4.20$
+0.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24.4% | 19.4% | 22.5% | 14.6% | 15.6% | 9.8% | 15.0% | 2.7% | -15.7% | -14.7% | -1.0% | 0.2% | |
| 1.8% | 3.5% | 3.6% | 6.6% | 7.3% | 8.6% | 13.1% | 9.1% | 7.8% | 8.2% | 7.3% | 6.5% | |
| 3.5% | 6.3% | 4.3% | 4.1% | 3.6% | 3.9% | 6.0% | 5.3% | 5.6% | 5.4% | 5.9% | 4.3% | |
| – | – | – | – | – | – | 12.8% | – | – | – | – | – | |
| -7.7% | -5.6% | -7.1% | 0.8% | 1.1% | -4.6% | -6.7% | 17.5% | -12.3% | 3.6% | -6.5% | -2.3% | |
| 1.8% | 3.3% | 0.7% | 0.8% | 1.1% | 1.0% | 1.5% | 2.6% | 6.7% | 9.7% | 3.5% | 3.3% | |
| -2.2% | 5.7% | -12.3% | -20.1% | -1.6% | -33.7% | 3.5% | 39.7% | -11.4% | 4.2% | -1.4% | -3.3% | |
| – | – | – | 55.3% | – | 39.9% | 61.0% | – | – | – | – | – | |
| -37.0% | -29.1% | -22.0% | -4.3% | – | -5.9% | -9.0% | 0.0% | – | – | – | – | |
| – | – | – | – | – | – | – | -32.8% | 0.0% | 5.3% | 0.0% | 10.2% | |
| -27.2% | -24.5% | -9.2% | 9.9% | -12.8% | 21.4% | 32.7% | -21.8% | -1.2% | 20.3% | -0.9% | 7.8% | |
| -5.1% | -0.1% | 0.6% | 4.7% | 1.1% | -2.1% | -3.2% | 20.5% | -28.4% | 9.9% | -3.5% | 4.8% | |
| 22.6% | 16.1% | 21.8% | 13.7% | 14.5% | 8.8% | 13.5% | 0.1% | -22.3% | -24.5% | -4.6% | -3.1% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.